» Articles » PMID: 25211123

Firmness Perception Influences Women's Preferences for Vaginal Suppositories

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2014 Sep 12
PMID 25211123
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Microbicides are being actively researched and developed as woman-initiated means to prevent HIV transmission during unprotected coitus. Along with safety and efficacy, assessing and improving compliance is a major area of research in microbicide development. We have developed carrageenan-based semisoft vaginal suppositories and have previously evaluated how physical properties such as firmness, size and shape influence women's willingness to try them. Firmness has previously been quantified in terms of small-strain storage modulus, G', however large-strain properties of the gels may also play a role in the firmness perception. In the current study we prepared two sets of suppositories with the same G' but different elongation properties at four different G' values (250, 2500, 12,500, 25,000 Pa): For convenience we refer to these as "brittle" and "elastic", although these terms were never provided to study participants. In the first of two tests conducted to assess preference, women compared pairs of brittle and elastic suppositories and indicated their preference. We observed an interaction, as women preferred brittle suppositories at lower G' (250, 2500 Pa) and elastic ones at a higher G' (25,000 Pa). In the second test, women evaluated samples across different G', rated the ease-of-insertion and willingness-to-try and ranked the samples in order of preference. Brittle suppositories at G' of 12,500 Pa were most preferred. In vitro studies were also conducted to measure the softening of the suppositories in contact with vaginal simulant fluid (VSF). Release of antiretroviral drug tenofovir in VSF was quantified for the brittle and elastic suppositories at G' of 12,500 Pa to determine the effect of suppository type on release. The initial rate of release was 20% slower with elastic suppositories as compared to brittle suppositories. Understanding how different physical properties simultaneously affect women's preferences and pharmacological efficacy in terms of drug release is required for the optimization of highly acceptable and efficacious microbicides.

Citing Articles

Distinct Sensory Hedonic Functions for Sourness in Adults.

Spinelli S, Hopfer H, Moulinier V, Prescott J, Monteleone E, Hayes J Food Qual Prefer. 2024; 116.

PMID: 38617134 PMC: 11014420. DOI: 10.1016/j.foodqual.2024.105152.


Release Kinetics of Metronidazole from 3D Printed Silicone Scaffolds for Sustained Application to the Female Reproductive Tract.

Herold S, Kyser A, Orr M, Mahmoud M, Lewis W, Lewis A Biomed Eng Adv. 2023; 5.

PMID: 37123989 PMC: 10136949. DOI: 10.1016/j.bea.2023.100078.


Use of Stated Preference Methods in HIV Treatment and Prevention Research in the United States: A Systematic Review.

Rodriguez C, Mitchell J AIDS Behav. 2023; 27(7):2328-2359.

PMID: 36809490 DOI: 10.1007/s10461-022-03962-5.


3D Printing of Paracetamol Suppositories: An Automated Manufacturing Technique for Individualized Therapy.

Domsta V, Krause J, Weitschies W, Seidlitz A Pharmaceutics. 2022; 14(12).

PMID: 36559169 PMC: 9785904. DOI: 10.3390/pharmaceutics14122676.


Design aspects of vaginal applicators that influence acceptance among target users.

Bakke A, Zaveri T, Higgins M, Ziegler G, Hayes J Sci Rep. 2021; 11(1):9802.

PMID: 33963262 PMC: 8105386. DOI: 10.1038/s41598-021-89284-3.


References
1.
Grammen C, Arien K, Venkatraj M, Joossens J, Van der Veken P, Heeres J . Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1. Antiviral Res. 2013; 101:113-21. DOI: 10.1016/j.antiviral.2013.11.005. View

2.
Akil A, Parniak M, Dezzuitti C, Moncla B, Cost M, Li M . Development and Characterization of a Vaginal Film Containing Dapivirine, a Non- nucleoside Reverse Transcriptase Inhibitor (NNRTI), for prevention of HIV-1 sexual transmission. Drug Deliv Transl Res. 2012; 1(3):209-222. PMC: 3375737. DOI: 10.1007/s13346-011-0022-6. View

3.
Berg J, Rosen R, Bregman D, Thompson L, Jensen K, Kiser P . "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels. AIDS Behav. 2013; 18(5):862-70. PMC: 4018755. DOI: 10.1007/s10461-013-0652-4. View

4.
Stone A, Gamble C . The quantity of vaginal fluid. Am J Obstet Gynecol. 1959; 78(2):279-81. DOI: 10.1016/0002-9378(59)90173-5. View

5.
Hemmerling A, Harrison W, Brown J, Moscicki B, Oziemkowska M, Bukusi E . Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations. Sex Transm Dis. 2012; 39(9):710-2. PMC: 3726043. DOI: 10.1097/OLQ.0b013e3182641f08. View